InsiderFlow

Yu-Waye Chu

FATE

Yu-Waye Chu serves as Chief Medical Officer at Fate Therapeutics, Inc. (FATE). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

7 trades

$1.05M

Net Position

Net Seller

$1.05M

Companies Traded

2

CTMX, FATE

Active Period

Apr 2021 – Mar 2025

7 total trades

Most Recent

Sell CTMX

Mar 18, 2025 · $2.4K

Yu-Waye Chu's Insider Trading at Fate Therapeutics, Inc. (FATE)

Buys

0 · $0.00

Sells

6 · $1.05M

Total Shares Bought

0

Total Shares Sold

29,159

FATE Price Chart
Loading chart...
DateTypeSharesAvg PriceValueShares After
Apr 19, 2023Sell2,532$6.57$16.6K142,993
Jan 11, 2023Sell7,825$5.24$41.0K143,208
Apr 21, 2022Sell4,062$35.37$143.7K151,033
Jan 13, 2022Sell3,965$48.51$192.3K122,211
Dec 13, 2021Sell7,500$51.46$385.9K131,161
Apr 20, 2021Sell3,275$83.30$272.8K67,200

Yu-Waye Chu's Insider Trading at CytomX Therapeutics, Inc. (CTMX)

Buys

0 · $0.00

Sells

1 · $2.4K

Total Shares Bought

0

Total Shares Sold

4,025

CTMX Price Chart
Loading chart...
DateTypeSharesAvg PriceValueShares After
Mar 18, 2025Sell4,025$0.60$2.4K0